Description Ikonisys is developing diagnostic tests for oncology and prenatal applications. The company's products are based on the CellOptics technology platform, which combines molecular diagnostics, imaging, and informatics services. It offers diagnostic products such as the oncoFISH testing line, which includes FDA approved tests for conditions including breast and bladder cancer, and the FastFISH amnio test kits, which are approved for identifying the chromosomal characteristics of birth defects such as Down syndrome, Edward's syndrome, and Patau syndrome. Ikonisys also offers analytical laboratory equipment for test processing, including the Ikoniscope and IkoniLAN digital microscopy systems.